Top Five Articles on 360Dx Last Week: Labcorp Asset Acquisition, Roche CE Mark for Mass Spec, More Last week, readers were most interested in Labcorp's acquisition of assets from MAWD, a CE mark for ...

Consolidation within the industry also remained brisk as cost and reimbursement concerns provided acquisition opportunities for large national outfits.

The companies said they plan to explore a range of questions including the clinical implementation of the Alzheimer's disease biomarker phosphorylated tau 217.

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: Labcorp to Acquire Select Assets of MAWD Pathology Group Roche Nabs CE Mark for New ...